Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 2/20 | 0.41 |
| ▸ | F3 | P13726 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 3/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 4/20 | 0.37 |
| ▸ | TERT | O14746 | 3/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.37 |
| ▸ | PPARD | Q03181 | 3/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | TOP1 | P11387 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5951823 | 1.00 | F7 (0.41) | F7F3TSHRALDH1A1FAAH | |
| SCHEMBL11122649 | 0.90 | FAAH (0.50) | F7F3FAAHTRPV1PPARG | |
| SCHEMBL18270282 | 0.90 | FAAH (0.50) | F7F3FAAHTRPV1PPARG | |
| SCHEMBL11122653 | 0.90 | FAAH (0.50) | F7F3FAAHTRPV1PPARG | |
| SCHEMBL18270292 | 0.90 | FAAH (0.50) | F7F3FAAHTRPV1PPARG | |
| SCHEMBL28723430 | 0.85 | TERT (0.31) | F7F3FAAHTRPV1PPARG | |
| SCHEMBL28240702 | 0.85 | — | — | |
| SCHEMBL5853081 | 0.82 | — | — | |
| SCHEMBL5853083 | 0.82 | — | — | |
| SCHEMBL25861862 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114341215-B | Curable composition | 株式会社日本触媒 | 2024-12-27 | — | — | CN | disclosed |
| US-12102992-B2 | Machine learning and statistical analysis for catalyst structure prediction and design | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-10-01 | — | — | US | disclosed |
| EP-3805282-B1 | METHOD FOR PRODUCING VINYL-ETHER-GROUP-CONTAINING (METH)ACRYLIC ACID ESTER POLYMER, VINYL-ETHER-GROUP-CONTAINING (METH)ACRYLIC ACID ESTER POLYMER, AND POLYMER COMPOSITION | NIPPON CATALYTIC CHEM IND (JP) | 2024-09-11 | — | — | EP | disclosed |
| US-20230330652-A1 | Machine Learning and Statistical Analysis for Catalyst Structure Prediction and Design | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2023-10-19 | — | — | US | disclosed |
| CN-112218901-B | Vinyl ether group-containing (meth) acrylate polymer, process for producing the same, and polymer composition | 株式会社日本触媒 | 2023-08-25 | — | — | CN | disclosed |
| CN-116134528-A | Machine learning and statistical analysis for catalyst structure prediction and design | 切弗朗菲利浦化学公司 | 2023-05-16 | — | — | CN | disclosed |
| US-11643490-B2 | Method for producing vinyl-ether-group-containing (meth)acrylic acid ester polymer, vinyl-ether-group-containing (meth)acrylic acid ester polymer, and polymer composition | NIPPON SHOKUBAI CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| EP-4165642-A1 | MACHINE LEARNING AND STATISTICAL ANALYSIS FOR CATALYST STRUCTURE PREDICTION AND DESIGN | Chevron Phillips Chemical Company LP (US) | 2023-04-19 | — | — | EP | disclosed |
| CN-114341215-A | Curable composition | 株式会社日本触媒 | 2022-04-12 | — | — | CN | disclosed |
| US-20210246245-A1 | METHOD FOR PRODUCING VINYL-ETHER-GROUP-CONTAINING (METH)ACRYLIC ACID ESTER POLYMER, VINYL-ETHER-GROUP-CONTAINING (METH)ACRYLIC ACID ESTER POLYMER, AND POLYMER COMPOSITION | NIPPON SHOKUBAI CO., LTD. (JP) | 2021-08-12 | — | — | US | disclosed |
| CN-107046802-A | Bimodal emulsion | 道康宁公司 | 2017-08-15 | — | — | CN | disclosed |
| EP-2573854-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-8993158-B2 | Nonaqueous electrolyte solution containing silyl ester group-containing phosphonic acid derivative, and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2015-03-31 | — | — | US | disclosed |
| EP-2573854-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2013-03-27 | — | — | EP | disclosed |
| US-20130071732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2013-03-21 | — | — | US | disclosed |
| US-7038070-B2 | Preparation of preparing substituted indanones | BASELL POLYOLEFINE GMBH (DE) | 2006-05-02 | — | — | US | disclosed |
| US-6963017-B2 | Preparation of preparing substituted indanones | BASELL POLYOLEFINE GMBH (DE) | 2005-11-08 | — | — | US | disclosed |
| EP-0968158-B1 | METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM | BASELL POLYOLEFINE GMBH (DE) | 2005-08-10 | — | — | EP | disclosed |
| US-20050033076-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2005-02-10 | — | — | US | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | PHOSPHO1, PSPH, SGK2 | F7 896/4885F3 3847/4885TSHR 4500/4885 |
| US-12102992-B2 | Machine learning and statistical analysis for catalyst structure prediction and design | MAX, CHRM4, SOD1 | F7 1076/4885F3 3161/4885TSHR 1848/4885 |
| US-20050033076-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP2J2, IDH3A | F7 416/4885F3 494/4885TSHR 4624/4885 |
| US-20230330652-A1 | Machine Learning and Statistical Analysis for Catalyst Structure Prediction and Design | MAX, CHRM4, SOD1 | F7 1076/4885F3 3161/4885TSHR 1848/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | F7 422/4885F3 484/4885TSHR 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.